BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 34116231)

  • 1. The miR-200-Zeb1 axis regulates key aspects of β-cell function and survival in vivo.
    Title AC; Silva PN; Godbersen S; Hasenöhrl L; Stoffel M
    Mol Metab; 2021 Nov; 53():101267. PubMed ID: 34116231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnolol regulates miR-200c-3p to inhibit epithelial-mesenchymal transition and retinoblastoma progression by modulating the ZEB1/E-cadherin axis in vitro and in vivo.
    Lai YH; Liu WL; Lee TY; Kuo CW; Liu YR; Huang CY; Chen YH; Chen IL; Wu SH; Wang SC; Lee PY; Liu CC; Lo J; Chang YC; Kuo HF; Hsieh CC; Li CY; Liu PL
    Phytomedicine; 2023 Feb; 110():154597. PubMed ID: 36603340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-200 is induced by thioredoxin-interacting protein and regulates Zeb1 protein signaling and beta cell apoptosis.
    Filios SR; Xu G; Chen J; Hong K; Jing G; Shalev A
    J Biol Chem; 2014 Dec; 289(52):36275-83. PubMed ID: 25391656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copy number gain of ZEB1 mediates a double-negative feedback loop with miR-33a-5p that regulates EMT and bone metastasis of prostate cancer dependent on TGF-β signaling.
    Dai Y; Wu Z; Lang C; Zhang X; He S; Yang Q; Guo W; Lai Y; Du H; Peng X; Ren D
    Theranostics; 2019; 9(21):6063-6079. PubMed ID: 31534537
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetic dissection of the miR-200-Zeb1 axis reveals its importance in tumor differentiation and invasion.
    Title AC; Hong SJ; Pires ND; Hasenöhrl L; Godbersen S; Stokar-Regenscheit N; Bartel DP; Stoffel M
    Nat Commun; 2018 Nov; 9(1):4671. PubMed ID: 30405106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
    Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-200a negatively regulates TGF-β
    Guo R; Hao G; Bao Y; Xiao J; Zhan X; Shi X; Luo L; Zhou J; Chen Q; Wei X
    Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1087-F1095. PubMed ID: 29357421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 9. MicroRNA-574-3p regulates epithelial mesenchymal transition and cisplatin resistance via targeting ZEB1 in human gastric carcinoma cells.
    Wang M; Zhang R; Zhang S; Xu R; Yang Q
    Gene; 2019 Jun; 700():110-119. PubMed ID: 30917930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-340 and ZEB1 negative feedback loop regulates TGF-β- mediated breast cancer progression.
    Hou LK; Yu Y; Xie YG; Wang J; Mao JF; Zhang B; Wang X; Cao XC
    Oncotarget; 2016 May; 7(18):26016-26. PubMed ID: 27036021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zinc-Dependent Regulation of ZEB1 and YAP1 Coactivation Promotes Epithelial-Mesenchymal Transition Plasticity and Metastasis in Pancreatic Cancer.
    Liu M; Zhang Y; Yang J; Zhan H; Zhou Z; Jiang Y; Shi X; Fan X; Zhang J; Luo W; Fung KA; Xu C; Bronze MS; Houchen CW; Li M
    Gastroenterology; 2021 Apr; 160(5):1771-1783.e1. PubMed ID: 33421513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of LncRNA XIST/ miR-101-3p/ZEB1 axis in EMT associated with silicosis.
    Li C; Xia J; Yao W; Yang G; Tian Y; Qi Y; Hao C
    Toxicol Lett; 2022 May; 360():11-19. PubMed ID: 35271943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-1199-5p and Zeb1 function in a double-negative feedback loop potentially coordinating EMT and tumour metastasis.
    Diepenbruck M; Tiede S; Saxena M; Ivanek R; Kalathur RKR; Lüönd F; Meyer-Schaller N; Christofori G
    Nat Commun; 2017 Oct; 8(1):1168. PubMed ID: 29079737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of Micro-429 on inhibition of cervical cancer cells through targeting ZEB1 and CRKL.
    Wang Y; Dong X; Hu B; Wang XJ; Wang Q; Wang WL
    Biomed Pharmacother; 2016 May; 80():311-321. PubMed ID: 27133071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KCNQ1OT1/miR-217/ZEB1 feedback loop facilitates cell migration and epithelial-mesenchymal transition in colorectal cancer.
    Bian Y; Gao G; Zhang Q; Qian H; Yu L; Yao N; Qian J; Liu B; Qian X
    Cancer Biol Ther; 2019; 20(6):886-896. PubMed ID: 30794031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance.
    Mutlu M; Raza U; Saatci Ö; Eyüpoğlu E; Yurdusev E; Şahin Ö
    J Mol Med (Berl); 2016 Jun; 94(6):629-44. PubMed ID: 27094812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circ_0007121 Facilitates Trophoblastic Cell Proliferation, Migration, and Invasion via the Regulation of the miR-421/ZEB1 Axis in Preeclampsia.
    Zhou F; Liu H; Zhang R; Sun Y
    Reprod Sci; 2022 Jan; 29(1):100-109. PubMed ID: 34462875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astragaloside IV inhibits epithelial-mesenchymal transition and pulmonary fibrosis via lncRNA-ATB/miR-200c/ZEB1 signaling pathway.
    Guan Y; Zhang J; Cai X; Cai Y; Song Z; Huang Y; Qian W; Pan Z; Zhang X
    Gene; 2024 Mar; 897():148040. PubMed ID: 38065426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UTMD inhibit EMT of breast cancer through the ROS/miR-200c/ZEB1 axis.
    Shi D; Guo L; Sun X; Shang M; Meng D; Zhou X; Liu X; Zhao Y; Li J
    Sci Rep; 2020 Apr; 10(1):6657. PubMed ID: 32313093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of the Pdx1/Ovol2/Zeb2 axis in dedifferentiated β-cells triggers the induction of genes associated with epithelial-mesenchymal transition in diabetes.
    de Jesus DS; Mak TCS; Wang YF; von Ohlen Y; Bai Y; Kane E; Chabosseau P; Chahrour CM; Distaso W; Salem V; Tomas A; Stoffel M; Rutter GA; Latreille M
    Mol Metab; 2021 Nov; 53():101248. PubMed ID: 33989778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.